Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Bevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2012 by Liaoning Tumor Hospital & Institute.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Chun Song, Liaoning Tumor Hospital & Institute
ClinicalTrials.gov Identifier:
NCT01763450
First received: December 28, 2012
Last updated: January 28, 2013
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2014
  Estimated Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)